Abstract

Neonatal abstinence syndrome (NAS) is a severe life-threatening condition, characterised as a spectrum of clinical manifestations observed in neonates where maternal opioid use, both prescribed and illicit, has taken place during pregnancy. This article was written after experience of the condition identified a learning outcome, a potential change in practice, and the differences between out-of-hospital and in-hospital managements of NAS. In addition, this article will aim to identify the complications of NAS, the severity of the condition, and the varying methods of treatment.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call